Intestinal Disease
41
6
8
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 41 trials
100.0%
+13.5% vs benchmark
17%
7 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (41)
Study of Normal Intestinal Development and Disease in Premature and Term Neonates
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
Gluten-free Diet in PSC and IBD
A Study to Evaluate Safety and Efficacy of PBK_M2502
Outcomes of Outpatients in an Gut Microbiota Clinic
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
CRC Detection Reliable Assessment With Blood
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF
DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice
Immune Responses to Gluten
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
SGM-101 in Colorectal Brain Metastases.
Effect of Probiotics on Patients With Congenital Heart Disease Following Cardiopulmonary Bypass
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Mental Stress and Bowel Preparation Quality
A Study to Evaluate Safety and Efficacy of PBK_M2101
Gut Microbial Changes After Periodontal Treatment
Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure
Endoscopist and Endoscope Motions During Colonoscopy
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly